申请人:MERCK FROSST CANADA INC.
公开号:EP0301692A2
公开(公告)日:1989-02-01
4,7-Benzofurandione derivatives of Formula I, pharmaceutical compositions, and methods of treatment are disclosed. These compounds are useful as inhibitors of mammalian leukotriene biosynthesis. As such, these compounds are useful therapeutic agents for treating allergic conditions, asthma, cardiovascular disorders, inflammation, psoriasis and allergic conjunctivitis. The compounds are also useful as analgesics and as cytoprotective agents. Also disclosed are novel intermediates useful for the preparation of the 4,7-benzofurandiones of this invention.
本研究公开了式 I 的 4,7-苯并呋喃二酮衍生物、药物组合物和治疗方法。这些化合物可作为哺乳动物白三烯生物合成的抑制剂。因此,这些化合物是治疗过敏性疾病、哮喘、心血管疾病、炎症、牛皮癣和过敏性结膜炎的有效治疗剂。这些化合物还可用作镇痛剂和细胞保护剂。本发明还公开了用于制备 4,7-苯并呋喃酮的新型中间体。